Fed. Circ. Upholds Rejection Of Cancer Patent Claim
A patent application describing a method for treating a rare form of cancer was appropriately rejected for lacking adequate written description because the patent's specification described only a single antibody, while...To view the full article, register now.
Already a subscriber? Click here to view full article